Giovanni F M Strippoli

Summary

Affiliation: Consorzio Mario Negri Sud
Country: Italy

Publications

  1. pmc Oral disease in adults treated with hemodialysis: prevalence, predictors, and association with mortality and adverse cardiovascular events: the rationale and design of the ORAL Diseases in hemodialysis (ORAL-D) study, a prospective, multinational, longitu
    Giovanni F M Strippoli
    Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, Italy
    BMC Nephrol 14:90. 2013
  2. ncbi request reprint Depression and sexual dysfunction in chronic kidney disease: a narrative review of the evidence in areas of significant unmet need
    Mariacristina Vecchio
    Correspondence and offprint requests to Giovanni F M Strippoli E mail
    Nephrol Dial Transplant 27:3420-8. 2012
  3. pmc Sexual dysfunction in women with ESRD requiring hemodialysis
    Giovanni F M Strippoli
    Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, S Maria Imbaro, Italy
    Clin J Am Soc Nephrol 7:974-81. 2012
  4. ncbi request reprint Prevalence and correlates of erectile dysfunction in men on chronic haemodialysis: a multinational cross-sectional study
    Mariacristina Vecchio
    Nephrol Dial Transplant 27:2479-88. 2012
  5. ncbi request reprint Meta-analysis: vitamin D compounds in chronic kidney disease
    Suetonia C Palmer
    Department of Medicine, Christchurch School of Medicine and Health Sciences, Christchurch, New Zealand
    Ann Intern Med 147:840-53. 2007
  6. doi request reprint Fluid and nutrient intake and risk of chronic kidney disease
    Giovanni F M Strippoli
    Centre for Kidney Research, NHMRC Centre for Clinical Research Excellence in Renal Medicine, Cochrane Renal Group, The Children s Hospital at Westmead, University of Sydney, Sydney, New South Wales, Australia
    Nephrology (Carlton) 16:326-34. 2011
  7. ncbi request reprint Haemoglobin targets: we were wrong, time to move on
    Giovanni F M Strippoli
    Cochrane Renal Group and Centre for Kidney Research and NHMRC Centre for Clinical Research Excellence in Renal Medicine, School of Public Health, University of Sydney, Sydney, New South Wales, Australia
    Lancet 369:346-50. 2007
  8. pmc Effects of the dose of erythropoiesis stimulating agents on cardiovascular events, quality of life, and health-related costs in hemodialysis patients: the clinical evaluation of the dose of erythropoietins (C.E. DOSE) trial protocol
    Giovanni F M Strippoli
    Department of Clinical Pharmacology and Epidemiology, Mario Negri Sud Consortium, 66030 S, Maria Imbaro CH, Italy
    Trials 11:70. 2010
  9. doi request reprint Antiplatelet agents for chronic kidney disease
    Suetonia C Palmer
    Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand
    Cochrane Database Syst Rev 2:CD008834. 2013
  10. doi request reprint Antiplatelet therapy to prevent hemodialysis vascular access failure: systematic review and meta-analysis
    Suetonia C Palmer
    Department of Medicine, University of Otago, Christchurch, New Zealand
    Am J Kidney Dis 61:112-22. 2013

Collaborators

Detail Information

Publications46

  1. pmc Oral disease in adults treated with hemodialysis: prevalence, predictors, and association with mortality and adverse cardiovascular events: the rationale and design of the ORAL Diseases in hemodialysis (ORAL-D) study, a prospective, multinational, longitu
    Giovanni F M Strippoli
    Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, Italy
    BMC Nephrol 14:90. 2013
    ..Recent data suggest periodontitis may be associated with mortality in dialysis patients and well-designed, larger studies are now required...
  2. ncbi request reprint Depression and sexual dysfunction in chronic kidney disease: a narrative review of the evidence in areas of significant unmet need
    Mariacristina Vecchio
    Correspondence and offprint requests to Giovanni F M Strippoli E mail
    Nephrol Dial Transplant 27:3420-8. 2012
    ....
  3. pmc Sexual dysfunction in women with ESRD requiring hemodialysis
    Giovanni F M Strippoli
    Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, S Maria Imbaro, Italy
    Clin J Am Soc Nephrol 7:974-81. 2012
    ..Sexual dysfunction was identified by the Female Sexual Function Index. Correlates of self-reported sexual dysfunction were identified by regression analyses...
  4. ncbi request reprint Prevalence and correlates of erectile dysfunction in men on chronic haemodialysis: a multinational cross-sectional study
    Mariacristina Vecchio
    Nephrol Dial Transplant 27:2479-88. 2012
    ....
  5. ncbi request reprint Meta-analysis: vitamin D compounds in chronic kidney disease
    Suetonia C Palmer
    Department of Medicine, Christchurch School of Medicine and Health Sciences, Christchurch, New Zealand
    Ann Intern Med 147:840-53. 2007
    ..Vitamin D compounds are widely used to prevent and treat secondary hyperparathyroidism...
  6. doi request reprint Fluid and nutrient intake and risk of chronic kidney disease
    Giovanni F M Strippoli
    Centre for Kidney Research, NHMRC Centre for Clinical Research Excellence in Renal Medicine, Cochrane Renal Group, The Children s Hospital at Westmead, University of Sydney, Sydney, New South Wales, Australia
    Nephrology (Carlton) 16:326-34. 2011
    ..We evaluated the association between fluid and nutrient intake and chronic kidney disease (CKD)...
  7. ncbi request reprint Haemoglobin targets: we were wrong, time to move on
    Giovanni F M Strippoli
    Cochrane Renal Group and Centre for Kidney Research and NHMRC Centre for Clinical Research Excellence in Renal Medicine, School of Public Health, University of Sydney, Sydney, New South Wales, Australia
    Lancet 369:346-50. 2007
  8. pmc Effects of the dose of erythropoiesis stimulating agents on cardiovascular events, quality of life, and health-related costs in hemodialysis patients: the clinical evaluation of the dose of erythropoietins (C.E. DOSE) trial protocol
    Giovanni F M Strippoli
    Department of Clinical Pharmacology and Epidemiology, Mario Negri Sud Consortium, 66030 S, Maria Imbaro CH, Italy
    Trials 11:70. 2010
    ..The Clinical Evaluation of the DOSe of Erythropoietins (C.E. DOSE) trial will assess the benefits and harms of a high versus a low fixed ESA dose for the management of anemia in patients with end stage kidney disease...
  9. doi request reprint Antiplatelet agents for chronic kidney disease
    Suetonia C Palmer
    Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand
    Cochrane Database Syst Rev 2:CD008834. 2013
    ..The risks and benefits of antiplatelet treatment may be different in people with chronic kidney disease (CKD) for whom occlusive atherosclerotic events are less prevalent, and bleeding hazards might be increased...
  10. doi request reprint Antiplatelet therapy to prevent hemodialysis vascular access failure: systematic review and meta-analysis
    Suetonia C Palmer
    Department of Medicine, University of Otago, Christchurch, New Zealand
    Am J Kidney Dis 61:112-22. 2013
    ..Antiplatelet agents may prevent hemodialysis vascular access failure, but potentially may be hazardous in people with end-stage kidney disease who have impaired hemostasis...
  11. doi request reprint Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis
    Suetonia C Palmer
    University of Otago, Christchurch, 2 Riccarton Avenue, PO Box 4345, Christchurch 8041, New Zealand
    Ann Intern Med 157:263-75. 2012
    ..Statins have uncertain benefits in persons with chronic kidney disease (CKD) because individual trials may have insufficient power to determine whether treatment effects differ with severity of CKD...
  12. pmc Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials
    Giovanni F M Strippoli
    NHMRC Centre for Clinical Research Excellence in Renal Medicine, School of Public Health, University of Sydney, Australia
    BMJ 336:645-51. 2008
    ..To analyse the benefits and harms of statins in patients with chronic kidney disease (pre-dialysis, dialysis, and transplant populations)...
  13. doi request reprint Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease
    Suetonia C Palmer
    University of Otago, Christchurch, New Zealand
    Ann Intern Med 153:23-33. 2010
    ..Previous meta-analyses suggest that treatment with erythropoiesis-stimulating agents (ESAs) in chronic kidney disease (CKD) increases the risk for death. Additional randomized trials have been recently completed...
  14. pmc Treatment options for sexual dysfunction in patients with chronic kidney disease: a systematic review of randomized controlled trials
    Mariacristina Vecchio
    Department of Clinical Pharmacology and Epidemiology, Mario Negri Sud Consortium, S Maria Imbaro, Italy
    Clin J Am Soc Nephrol 5:985-95. 2010
    ..Sexual dysfunction is very common in patients with chronic kidney disease (CKD), but treatment options are limited. The benefits and harms of existing interventions for treatment of sexual dysfunction were assessed in patients with CKD...
  15. doi request reprint Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
    Elisabeth M Hodson
    Centre for Kidney Research, The Children s Hospital at Westmead, Westmead, Australia
    Cochrane Database Syst Rev 2:CD003774. 2013
    ..This is an update of a review first published in 2005 and updated in 2008...
  16. ncbi request reprint Catheter-related interventions to prevent peritonitis in peritoneal dialysis: a systematic review of randomized, controlled trials
    Giovanni F M Strippoli
    NHMRC Centre for Clinical Research Excellence in Renal Medicine, Cochrane Renal Group, Locked Bag 4001, University of Sydney, Australia
    J Am Soc Nephrol 15:2735-46. 2004
    ....
  17. doi request reprint Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis
    Suetonia C Palmer
    Department of Medicine, University of Otago, Christchurch, New Zealand
    JAMA 305:1119-27. 2011
    ..Clinical practice guidelines on the management of mineral and bone disorders due to chronic kidney disease recommend specific treatment target levels for serum phosphorus, parathyroid hormone, and calcium...
  18. doi request reprint Association Between Depression and Death in People With CKD: A Meta-analysis of Cohort Studies
    Suetonia C Palmer
    Department of Medicine, University of Otago Christchurch, New Zealand
    Am J Kidney Dis 62:493-505. 2013
    ..Interventions to reduce mortality in CKD consistently have been ineffective and new strategies are needed...
  19. ncbi request reprint Meta-analysis of biochemical and patient-level effects of calcimimetic therapy
    Giovanni F M Strippoli
    NHMRC Centre for Clinical Research Excellence in Renal Medicine, Cochrane Renal Group, School of Public Health, University of Sydney, Australia
    Am J Kidney Dis 47:715-26. 2006
    ..We conducted a meta-analysis to evaluate outcomes of therapy with these novel agents...
  20. ncbi request reprint Hemoglobin targets for the anemia of chronic kidney disease: a meta-analysis of randomized, controlled trials
    Giovanni F M Strippoli
    Centre for Kidney Research, NHMRC Centre for Clinical Research Excellence in Renal Medicine, Cochrane Renal Group, Locked Bag 4001, The Children s Hospital at Westmead and the University of Sydney, Westmead, NSW 2145, Australia
    J Am Soc Nephrol 15:3154-65. 2004
    ..There is insufficient data to guide decisions in patients without cardiovascular disease or in the predialysis population...
  21. doi request reprint Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies
    Suetonia Palmer
    Department of Medicine, University of Otago, Christchurch, Christchurch, New Zealand
    Kidney Int 84:179-91. 2013
    ..Given the potential prevalence of depression in the setting of CKD, randomized trials to evaluate effects of interventions for depression on patient-centered outcomes are needed. ..
  22. ncbi request reprint Role of blood pressure targets and specific antihypertensive agents used to prevent diabetic nephropathy and delay its progression
    Giovanni F M Strippoli
    National Health and Medical Research Council Centre for Clinical Research Excellence in Renal Medicine, University of Sydney, Australia
    J Am Soc Nephrol 17:S153-5. 2006
    ..On the basis of available RCT evidence, ACEi are the only agents with proven renal benefit in patients who have diabetes with no nephropathy and the only agents with proven survival benefit in patients who have diabetes with nephropathy...
  23. doi request reprint Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease: a systematic review and meta-analysis
    Suetonia C Palmer
    University of Otago, Christchurch, New Zealand
    Ann Intern Med 156:445-59. 2012
    ....
  24. ncbi request reprint Preemptive treatment for cytomegalovirus viremia to prevent cytomegalovirus disease in solid organ transplant recipients
    Giovanni F M Strippoli
    NHMRC Centre for Clinical Research Excellence in Renal Medicine, Centre for Kidney Research, The Children s Hospital at Westmead, Sydney, Australia
    Transplantation 81:139-45. 2006
    ..This study was conducted to evaluate the efficacy of preemptive treatment in preventing symptomatic CMV disease...
  25. ncbi request reprint Interventions for preventing bone disease in kidney transplant recipients: a systematic review of randomized controlled trials
    Suetonia C Palmer
    Department of Nephrology, Christchurch Hospital, Christchurch, New Zealand
    Am J Kidney Dis 45:638-49. 2005
    ..This study was conducted to assess the evidence available to guide targeted treatment to reduce bone disease in transplant recipients...
  26. pmc Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials
    Suetonia C Palmer
    Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand
    PLoS Med 10:e1001436. 2013
    ....
  27. doi request reprint How to read a nephrology systematic review
    Suetonia C Palmer
    Department of Medicine, University of Otago, Christchurch, New Zealand
    Nephrology (Carlton) 15:158-64. 2010
    ..We summarize the features of a systematic review that should be looked for when considering the accuracy and validity of its results - particularly when applying the outcomes of a systematic review to a clinical question...
  28. ncbi request reprint Antihypertensive agents for primary prevention of diabetic nephropathy
    Giovanni F M Strippoli
    Cochrane Renal Group, Centre for Kidney Research, Locked Bag 4001, Children s Hospital at Westmead, Westmead, NSW 2145, Australia
    J Am Soc Nephrol 16:3081-91. 2005
    ....
  29. pmc Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials
    Giorgia De Berardis
    Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, Via Nazionale 8 A, 66030 S Maria Imbaro, Italy
    BMJ 339:b4531. 2009
    ..To evaluate the benefits and harms of low dose aspirin in people with diabetes and no cardiovascular disease...
  30. doi request reprint Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials
    Ausilia Maione
    Department of Pharmacology and Clinical Epidemiology, Mario Negri Sud Consortium, S Maria Imbaro Ch, Italy
    Nephrol Dial Transplant 26:2827-47. 2011
    ..We examined the benefits and risks of these agents in people with albuminuria and one or more cardiovascular risk factors...
  31. pmc Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review
    Monica Franciosi
    Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, S Maria Imbaro Ch, Chieti, Italy
    PLoS ONE 8:e71583. 2013
    ..There is ongoing debate about a potential protective action of metformin. To summarize evidence on the association between metformin and risk of cancer and cancer mortality in patients with diabetes...
  32. doi request reprint High-flux versus low-flux membranes for end-stage kidney disease
    Suetonia C Palmer
    Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand
    Cochrane Database Syst Rev 9:CD005016. 2012
    ..Clinical practice guidelines regarding the use of high-flux haemodialysis membranes vary widely...
  33. ncbi request reprint Identifying patients at risk for microalbuminuria via interaction of the components of the metabolic syndrome: a cross-sectional analytic study
    Monica Franciosi
    Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, Via Nazionale, 66030 S Maria Imbaro CH, Italy
    Clin J Am Soc Nephrol 2:984-91. 2007
    ..The objective of this study was to investigate correlates of risk for having microalbuminuria in individuals with one or more cardiovascular risk factors...
  34. ncbi request reprint Is renal impairment a predictor of the incidence of cataract or cataract surgery? Findings from a population-based study
    Son C Huynh
    Centre for Vision Research, Department of Ophthalmology and Westmead Millennium Institute, University of Sydney, Sydney, NSW, Australia
    Ophthalmology 112:293-300. 2005
    ..To explore the relationship between creatinine clearance, an estimate of glomerular filtration rate, and 5-year incidence of cataract and cataract surgery...
  35. ncbi request reprint Risk factors for the development and progression of renal diseases in disadvantaged populations: role of the renin-angiotensin system blockade
    Ausilia Maione
    Mario Negri Sud Consortium, S Maria Imbaro Ch, Italy
    Ethn Dis 19:S1-86-9. 2009
    ..It is plausible that these disadvantaged groups may benefit more than others from a renal and cardiovascular prevention program, but considerable under-recognition and under-treatment of these conditions still exist...
  36. doi request reprint Induction and maintenance treatment of proliferative lupus nephritis: a meta-analysis of randomized controlled trials
    Lorna K Henderson
    Cochrane Renal Group, Centre for Kidney Research, The Children s Hospital at Westmead, Sydney, Australia
    Am J Kidney Dis 61:74-87. 2013
    ..Treatment regimens combining cyclophosphamide with steroids preserve kidney function but have significant side effects. Newer immunosuppressive agents may have improved toxicity profiles...
  37. pmc Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review
    Giovanni F M Strippoli
    NHMRC Centre for Clinical Research Excellence in Renal Medicine, Cochrane Renal Group, Children s Hospital at Westmead, Westmead, NSW 2145, Australia
    BMJ 329:828. 2004
    ..To evaluate the effects of angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor antagonists (AIIRAs) on renal outcomes and all cause mortality in patients with diabetic nephropathy...
  38. ncbi request reprint Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials
    Elisabeth M Hodson
    National Health and Medical Research Council Centre for Clinical Research Excellence, Centre for Kidney Research, The Children s Hospital at Westmead, Sydney, Australia
    Lancet 365:2105-15. 2005
    ..We undertook a systematic review to investigate whether this approach affects risks of cytomegalovirus disease and death...
  39. ncbi request reprint Antimicrobial agents to prevent peritonitis in peritoneal dialysis: a systematic review of randomized controlled trials
    Giovanni F M Strippoli
    Centre for Kidney Research, National Health and Medical Research Council Centre for Clinical Research Excellence in Renal Medicine, Cochrane Renal Group, Children s Hospital at Westmead, University of Sydney, Sydney, Australia
    Am J Kidney Dis 44:591-603. 2004
    ..Oral, nasal, and topical antibiotic prophylaxis; exit-site disinfectants; and other antimicrobial interventions are used to prevent it. This study was conducted to assess what evidence supports these approaches...
  40. ncbi request reprint A pegylated epoetin in anaemia of renal disease: non-inferiority for an unvalidated surrogate
    Rowan G Walker
    North West Dialysis, Royal Melbourne Hospital, Melbourne, Vic, Australia
    Lancet 370:1395-6. 2007
  41. ncbi request reprint Comparison of hemodialysis, hemofiltration, and acetate-free biofiltration for ESRD: systematic review
    Kannaiyan S Rabindranath
    Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, UK
    Am J Kidney Dis 45:437-47. 2005
    ....
  42. ncbi request reprint Hypothesis versus association: the optimal hemoglobin target debate
    Giovanni F M Strippoli
    Am J Kidney Dis 46:970-3. 2005
  43. ncbi request reprint Antihypertensive agents in patients with diabetes: trade-off between renal and cardiovascular protection
    Sankar D Navaneethan
    Division of Nephrology, University of Rochester, 601 Elmwood Drive, Box 675, Rochester, NY 14642, USA
    Diabetes Educ 32:596-602. 2006
    ..Use of any agent that provides tight control of blood pressure is indicated in patients with diabetes but without nephropathy...
  44. ncbi request reprint A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study
    Carlo Manno
    Department of Emergency and Organ Transplantation, Renal, Dialysis and Transplant Unit, University of Bari, Bari, Italy
    Am J Kidney Dis 49:763-75. 2007
    ..We evaluated factors associated with long-term renal survival by using a novel simplified histological classification...
  45. doi request reprint The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial
    Antonio Santoro
    Nephrology, Dialysis, and Hypertension Department, Policlinico S Orsola Malpighi, Bologna, Italy
    Am J Kidney Dis 52:507-18. 2008
    ....
  46. pmc Statins in patients with chronic kidney disease: evidence from systematic reviews and randomized clinical trials
    Sankar D Navaneethan
    Department of Medicine, Unity Health System, Rochester, New York, United States of America
    PLoS Med 3:e123. 2006